68 Result(s)

Article

External validation and comparison of magnetic resonance imaging-based risk prediction models for prostate biopsy stratification

Magnetic resonance imaging (MRI) is a promising tool for risk assessment, potentially reducing the burden of unnecessary prostate biopsies. Risk prediction models that incorporate MRI data have gained attentio...

Romain Diamand, Karsten Guenzel, Teddy Jabbour… in World Journal of Urology (2024)

Article

MRI lesion size is more important than the number of positive biopsy cores in predicting adverse features and recurrence after radical prostatectomy: implications for active surveillance criteria in intermediate-risk patients

To determine associations between prostate cancer (PCa) tumor burden measured on biopsy or multiparametric magnetic resonance imaging (mpMRI) and outcomes in intermediate-risk (IR) International Society of Uro...

Michael Baboudjian, Alessandro Uleri… in Prostate Cancer and Prostatic Diseases (2024)

Article

The impact of prostate volume estimation on the risk‐adapted biopsy decision based on prostate-specific antigen density and magnetic resonance imaging score

Utility of prostate-specific antigen density (PSAd) for risk-stratification to avoid unnecessary biopsy remains unclear due to the lack of standardization of prostate volume estimation. We evaluated the impact...

Arthur Baudewyns, Karsten Guenzel, Adam Halinski… in World Journal of Urology (2024)

Article

Predicting contralateral extraprostatic extension in unilateral high-risk prostate cancer: a multicentric external validation study

Accurate prediction of extraprostatic extension (EPE) is crucial for decision-making in radical prostatectomy (RP), especially in nerve-sparing strategies. Martini et al. introduced a three-tier algorithm for ...

Romain Diamand, Jean-Baptiste Roche, Vito Lacetera… in World Journal of Urology (2024)

Article

An updated model for predicting side-specific extraprostatic extension in the era of MRI-targeted biopsy

Accurate prediction of extraprostatic extension (EPE) is pivotal for surgical planning. Herein, we aimed to provide an updated model for predicting EPE among patients diagnosed with MRI-targeted biopsy.

Alberto Martini, Lieke Wever, Timo F. W. Soeterik… in Prostate Cancer and Prostatic Diseases (2024)

Article

Reply to: Fact, overdiagnosis cannot be evaluated by comparing histological grading of prostate biopsy to prostatectomy specimen

Alberto Martini, Guillaume Ploussard in Prostate Cancer and Prostatic Diseases (2023)

Article

What is the ideal combination therapy in de novo, oligometastatic, castration-sensitive prostate cancer?

To review current evidence regarding the management of de novo, oligometastatic, castration-sensitive prostate cancer (PCa).

Michael Baboudjian, Guilhem Roubaud, Gaëlle Fromont… in World Journal of Urology (2023)

Article

Expanding inclusion criteria for active surveillance in intermediate-risk prostate cancer: a machine learning approach

To develop new selection criteria for active surveillance (AS) in intermediate-risk (IR) prostate cancer (PCa) patients.

Michael Baboudjian, Alberto Breda, Thierry Roumeguère… in World Journal of Urology (2023)

Article

Prostate cancer risk, screening and management in patients with germline BRCA1/2 mutations

Mutations in the BRCA1 and BRCA2 tumour suppressor genes are associated with prostate cancer risk; however, optimal screening protocols for individuals with these mutations have been a subject of debate. Several ...

Pawel Rajwa, Fahad Quhal, Benjamin Pradere, Giorgio Gandaglia… in Nature Reviews Urology (2023)

Article

Association between age and efficacy of combination systemic therapies in patients with metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis

Combination systemic therapies have become the standard for metastatic hormone-sensitive prostate cancer (mHSPC). However, the effect of age on oncologic outcomes remains unknown. Our aim was to perform a syst...

Pawel Rajwa, Takafumi Yanagisawa… in Prostate Cancer and Prostatic Diseases (2023)

Article

Micro-ultrasound-guided biopsies versus systematic biopsies in the detection of prostate cancer: a systematic review and meta-analysis

The diagnosis of prostate cancer (PCa) still relies on the performance of both targeted (TB) and systematic biopsies (SB). Micro-ultrasound (mUS)-guided biopsies demonstrated a high sensitivity in detecting cl...

Charles Dariane, Guillaume Ploussard, Eric Barret… in World Journal of Urology (2023)

Article

Optimizing multiparametric magnetic resonance imaging-targeted biopsy and prostate cancer grading accuracy

To assess the most efficient biopsy method to improve International Society of Urological Pathology (ISUP) grade group accuracy with final pathology of the radical prostatectomy (RP) specimen in the era of mag...

Romain Diamand, Alexandre Peltier, Jean-Baptiste Roche… in World Journal of Urology (2023)

Article

Heterogeneity of contemporary grade group 4 prostate cancer in radical prostatectomy specimens

The aim was to evaluate the prognostic role of sub-categories of ISUP 4 prostate cancer (PCa) on final pathology, and assess the tumor architecture prognostic role for predicting biochemical recurrence (BCR) a...

Alberto Martini, Alae Touzani, Jean-Baptiste Beauval… in World Journal of Urology (2022)

Article

Grade group 1 prostate cancer on biopsy: are we still missing aggressive disease in the era of image-directed therapy?

Recently, Eggener et al. reignited a debate consisting to redefine Gleason Grade Group (GGG) 1 prostate cancer (PCa) as a precancerous lesion to reduce overdiagnosis and overtreatment. However, historical cohorts...

Michael Baboudjian, Mathieu Roumiguié, Alexandre Peltier… in World Journal of Urology (2022)

Article

Neoadjuvant chemotherapy does not increase peri-operative morbidity following radical cystectomy

To determine whether use of neoadjuvant chemotherapy (NAC) is associated with a higher risk of post-operative complications following radical cystectomy (RC) for bladder cancer (BCa).

Amandeep Arora, Ahmed S. Zugail, Felipe Pugliesi… in World Journal of Urology (2022)